OxitopePharma_Logo.jpg
Oxitope Appoints Leading Interventional Cardiologist Gregg Stone to Advisory Board for Myocardial Reperfusion Injury
November 28, 2022 07:00 ET | Oxitope Pharma
PRESS RELEASE Oxitope Appoints Leading Interventional Cardiologist Gregg Stone to Advisory Board for Myocardial Reperfusion Injury Naarden, The Netherlands, 28 November 2022 – Oxitope Pharma B.V....
Healthtech Solutions, Inc. (HLTT), Parent Company of Medi-Scan Inc., Announces Incorporation of a New Subsidiary Called RevHeart, Inc.
March 16, 2021 08:30 ET | Healthtech Solutions, Inc.
New subsidiary will further the Company’s research into treating COVID-related heart muscle injury.  A patent has been filed for a therapy to ameliorate and potentially repair myocardial damage. NEW...